You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華森製藥(002907.SZ):收到藥品生產許可證 主要涉及奧利司他膠囊生產場地變更
格隆匯 01-16 21:13

格隆匯1月16日丨華森製藥(002907.SZ)公佈,公司於近日收到重慶市藥品監督管理局頒發的《藥品生產許可證》(許可證編號:渝 20150018),此次主要涉及奧利司他膠囊(國藥準字:H20103180)生產場地變更。同時,該產品已於國家藥品監督管理局官網備案公示。

奧利司他膠囊(國藥準字:H20103180)生產場地變更為:重慶市榮昌區工業園區一車間膠囊劑生產線;重慶市榮昌區昌州街道板橋路143號503車間硬膠囊劑生產線。奧利司他膠囊:用於肥胖或體重超重患者(體重指數≥24)的治療。

次《藥品生產許可證》變更及因此帶來的藥品備案信息變更有利於產品的模化生產形成規模化效應。同時,有利於公司自有品牌(曲暢)奧利司他膠囊生產供應,進而更好滿足市場需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account